Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer

BMC Cancer

Volumn 5, Issue , 2005, Pages

  Thorwarth, Daniela ^a   Eschmann, Susanne Martina ^a   Scheiderbauer, Jutta ^a   Paulsen, Frank ^a   Alber, Markus ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE 18; FLUOROURACIL; MITOMYCIN; PACLITAXEL; UNCLASSIFIED DRUG; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; MISONIDAZOLE; RADIOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER TISSUE; CLINICAL ARTICLE; COMPARTMENT MODEL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOXIA; INTENSITY MODULATED RADIATION THERAPY; MALE; MATHEMATICAL COMPUTING; PERFUSION; POSITRON EMISSION TOMOGRAPHY; PROBABILITY; RADIATION DOSE; RANK SUM TEST; TREATMENT OUTCOME; VALIDATION PROCESS; ANOXIA; COMPUTER PROGRAM; HEAD AND NECK TUMOR; IMAGE PROCESSING; KINETICS; METABOLISM; METHODOLOGY; MIDDLE AGED; STATISTICAL MODEL;

AGED; ANOXIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; MALE; MIDDLE AGED; MISONIDAZOLE; MODELS, STATISTICAL; POSITRON-EMISSION TOMOGRAPHY; RADIATION-SENSITIZING AGENTS; SOFTWARE; TREATMENT OUTCOME;

EID: 29144477687     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-5-152     Document Type: Article

References (27)

1. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338(25):1798-1804.
2. Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, Lammert I, Jahnke K, Stueben G, Herrmann T, Bamberg M, Wust P, Hinkelbein W, Wernecke K: Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005, 23(6):1125-1135.
3. Coleman CN, Mitchell JB, Camphausen K: Tumor Hypoxia: Chicken, Egg, or a Piece of the Farm? (editorial). J Clin Oncol 2002, 20:610-615.
4. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP: Tumor Hypoxia has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer. J Clin Oncol 2002, 20:680-687.
5. Weinmann M, Belka C, Plasswilm L: Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 2004, 27:83-90.
6. Weinmann M, Jendrossek V, Guner D, Goecke B, Belka C: Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondiral apoptotic pathways. FASEB 2004, 18(15):1906-1908.
7. Nordsmark M, Overgaard M, Overgaard J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996, 41:31-39.
8. Nordsmark M, Overgaard J: A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 2000, 57:39-43.
9. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997, 38(2):285-289.
10. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993, 26:35-50.
11. 18F]fluoromisonidazole: A pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996, 36(2):417-428.
12. Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, Krohn KA, Griffin TW: Imaging of hypoxia in human tumours with [F-18]fluoromisonidazole. 1992 Int J Radiat Oncol Biol Phys, 22:199-212.
13. 18F-Misonidazole PET in Non-Small Cell Lung Cancer and Head and Neck Cancer Before Radiotherapy. J Nucl Med 2005, 46:253-260.
14. 18F-Fluoroazomycin Arabinoside. J Nucl Med 2005, 46:106-113.
15. 60Cu-ATSM: Relationship to therapeutic response - a preliminary report. Int J Radiat Oncol Biol Phys 2003, 55(5):1233-1238.
16. 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 2003, 67:339-344.
17. Rasey JS, Nelson NJ, Chin L, Evans ML, Grunbaum Z: Characteristics of the binding of labeled fluoromisonidazole in cells in vitro. Radiat Res 1990, 122(3):301-308.
18. Ling J C C Humm, Larson S, Amols H, Fuks Z, Leibel S, Koutcher JA: Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 2000, 47(3):551-560.
19. Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ: A novel approach to overcome hypoxic tumour resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2001, 49(4):1171-1182.
20. Alber F M and Paulsen F, Eschmann SM, Machulla HJ: On biologically conformal boost dose optimization. Phys Med Biol 2003, 48:N31-N35.
21. Ljungkvist ASE, Bussink J, Rijken PFJW, Kaanders JH, van der Kogel AJ, Denekamp J: Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2002, 54:215-228.
22. Janssen HL, Haustermans KMG, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Semenza GL, Varia MA, Balm AJ, van Velthuysen MF, Delaere P, Sciot R, Begg AC: HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumours. Int J Radiat Oncol Biol Phys 2002, 54(5):1537-1549.
23. Janssen HL, Hoebers FJ, Sprong D, Goethals L, Williams KJ, Stratford IJ, Haustermans HM, Balm AJ, Begg AC: Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumours. Radiother Oncol 2004, 70:91-97.
24. Viola P, Wells WM: Alignment by Maximization of Mutual Information. Int J Comp Vision 1997, 24(2):137-154.
25. 18F]-Fmiso PET data to analys. Phys Med Biol 2005, 50:2209-2224.
26. Plataniotis GA, Theofanopoulou ME, Kalogera-Fountzila A, Haritanti A, Ciuleanou E, Ghilezan N, Zamboglou N, Dimitriadis A, Sofroniadis I, Fountzilas G: Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 2004, 59(4):1018-1026.
27. Denekamp J, Dasu A: Inducible Repair and the Two Forms of Tumour Hypoxia - Time fir a Paradigm Shift. Acta Oncol 1999, 38(7):903-918.